TrendRadars > News > Madrigal’s stock rallies about 200% after sharing positive data about its NASH treatment candidate
Madrigal’s stock rallies about 200% after sharing positive data about its NASH treatment candidate
Madrigal's stock rallies about 200% after sharing positive data about its NASH treatment candidate,Madrigal's stock rallies about 200% after sharing positive data about its NASH treatment candidate,Shares of Madrigal Pharmaceuticals Inc. undefined soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3...

Madrigal’s stock rallies about 200% after sharing positive data about its NASH treatment candidate

Madrigal’s stock rallies about 200% after sharing positive data about its NASH treatment candidate,Shares of Madrigal Pharmaceuticals Inc. undefined soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3…